CROSS COUNTRY HEALTHCARE INC
CCRN$428M
Small CapNASDAQServices-Help Supply Services🇺🇸North AmericaBOCA RATON9.6K employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Mar 31, 2026
18dMarket Overview
Stock performance and key metrics
CCRN News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
LAENNEC (Human Placenta Hydrolysate) IV
Chronic Liver Disease
LAENNEC (Human Placenta Hydrolysate)
Chronic Liver Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
LAENNEC (Human Placenta Hydrolysate) IV | Phase 3 | Chronic Liver Disease | - | - |
LAENNEC (Human Placenta Hydrolysate) | Phase 2 | Chronic Liver Disease | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply